View in EDS HTML Full Text PDF Full Text

Author Correction: Functional dissection of inherited non-coding variation influencing multiple myeloma risk.

Saved in:
Bibliographic Details
Title: Author Correction: Functional dissection of inherited non-coding variation influencing multiple myeloma risk.
Authors: Ajore R; Hematology and Transfusion Medicine, Department of Laboratory Medicine, BMC B13, 221 84, Lund, Sweden., Niroula A; Hematology and Transfusion Medicine, Department of Laboratory Medicine, BMC B13, 221 84, Lund, Sweden.; Broad Institute of Massachusetts Institute of Technology and Harvard University, 415 Main Street, Boston, MA, 02142, USA., Pertesi M; Hematology and Transfusion Medicine, Department of Laboratory Medicine, BMC B13, 221 84, Lund, Sweden., Cafaro C; Hematology and Transfusion Medicine, Department of Laboratory Medicine, BMC B13, 221 84, Lund, Sweden., Thodberg M; Hematology and Transfusion Medicine, Department of Laboratory Medicine, BMC B13, 221 84, Lund, Sweden., Went M; Division of Genetics and Epidemiology, The Institute of Cancer Research, 123 Old Brompton Road, London, SW7 3RP, United Kingdom., Bao EL; Broad Institute of Massachusetts Institute of Technology and Harvard University, 415 Main Street, Boston, MA, 02142, USA.; Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Duran-Lozano L; Hematology and Transfusion Medicine, Department of Laboratory Medicine, BMC B13, 221 84, Lund, Sweden., Lopez de Lapuente Portilla A; Hematology and Transfusion Medicine, Department of Laboratory Medicine, BMC B13, 221 84, Lund, Sweden., Olafsdottir T; deCODE Genetics/Amgen Inc., Sturlugata 8, 101, Reykjavik, Iceland., Ugidos-Damboriena N; Hematology and Transfusion Medicine, Department of Laboratory Medicine, BMC B13, 221 84, Lund, Sweden., Magnusson O; deCODE Genetics/Amgen Inc., Sturlugata 8, 101, Reykjavik, Iceland., Samur M; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Lareau CA; Broad Institute of Massachusetts Institute of Technology and Harvard University, 415 Main Street, Boston, MA, 02142, USA.; Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Halldorsson GH; deCODE Genetics/Amgen Inc., Sturlugata 8, 101, Reykjavik, Iceland., Thorleifsson G; deCODE Genetics/Amgen Inc., Sturlugata 8, 101, Reykjavik, Iceland., Norddahl GL; deCODE Genetics/Amgen Inc., Sturlugata 8, 101, Reykjavik, Iceland., Gunnarsdottir K; deCODE Genetics/Amgen Inc., Sturlugata 8, 101, Reykjavik, Iceland., Försti A; German Cancer Research Center (DKFZ), Im Neuenheimer Feld 580, D-69120, Heidelberg, Germany.; Hopp Children's Cancer Center, Heidelberg, Germany., Goldschmidt H; Department of Internal Medicine V, University Hospital of Heidelberg, 69120, Heidelberg, Germany., Hemminki K; German Cancer Research Center (DKFZ), Im Neuenheimer Feld 580, D-69120, Heidelberg, Germany.; Faculty of Medicine and Biomedical Center in Pilsen, Charles University in Prague, Prague, 30605, Czech Republic., van Rhee F; Hopp Children's Cancer Center, Heidelberg, Germany., Kimber S; Division of Genetics and Epidemiology, The Institute of Cancer Research, 123 Old Brompton Road, London, SW7 3RP, United Kingdom., Sperling AS; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Kaiser M; Division of Genetics and Epidemiology, The Institute of Cancer Research, 123 Old Brompton Road, London, SW7 3RP, United Kingdom., Anderson K; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Jonsdottir I; deCODE Genetics/Amgen Inc., Sturlugata 8, 101, Reykjavik, Iceland., Munshi N; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Rafnar T; deCODE Genetics/Amgen Inc., Sturlugata 8, 101, Reykjavik, Iceland., Waage A; Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, Box 8905, N-7491, Trondheim, Norway., Weinhold N; German Cancer Research Center (DKFZ), Im Neuenheimer Feld 580, D-69120, Heidelberg, Germany.; Department of Internal Medicine V, University Hospital of Heidelberg, 69120, Heidelberg, Germany., Thorsteinsdottir U; deCODE Genetics/Amgen Inc., Sturlugata 8, 101, Reykjavik, Iceland., Sankaran VG; Broad Institute of Massachusetts Institute of Technology and Harvard University, 415 Main Street, Boston, MA, 02142, USA.; Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Harvard Stem Cell Institute, Cambridge, MA, USA., Stefansson K; deCODE Genetics/Amgen Inc., Sturlugata 8, 101, Reykjavik, Iceland., Houlston R; Division of Genetics and Epidemiology, The Institute of Cancer Research, 123 Old Brompton Road, London, SW7 3RP, United Kingdom., Nilsson B; Hematology and Transfusion Medicine, Department of Laboratory Medicine, BMC B13, 221 84, Lund, Sweden. bjorn.nilsson@med.lu.se.; Broad Institute of Massachusetts Institute of Technology and Harvard University, 415 Main Street, Boston, MA, 02142, USA. bjorn.nilsson@med.lu.se.
Source: Nature communications [Nat Commun] 2022 Dec 13; Vol. 13 (1), pp. 7725. Date of Electronic Publication: 2022 Dec 13.
Publication Type: Published Erratum
Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE; PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2041-1723
DOI:10.1038/s41467-022-35411-1